219 related articles for article (PubMed ID: 20522375)
21. Could HPV testing become the sole primary cervical screening test?
Sasieni P; Cuzick J
J Med Screen; 2002; 9(2):49-51. PubMed ID: 12133918
[No Abstract] [Full Text] [Related]
22. Extended duration of the detectable stage by adding HPV test in cervical cancer screening.
van den Akker-van Marie ME; van Ballegooijen M; Rozendaal L; Meijer CJ; Habbema JD
Br J Cancer; 2003 Nov; 89(10):1830-3. PubMed ID: 14612887
[TBL] [Abstract][Full Text] [Related]
23. Correlation of Pap smear, cervical biopsy, and clinical follow-up with an HPV typing microarray system.
Nuovo GJ; Bartholomew D; Jung WW; Han IK; Um T; Grabarz DF; Lee DJ; McCabe RT
Diagn Mol Pathol; 2008 Jun; 17(2):107-11. PubMed ID: 18382353
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus and Papanicolaou tests to screen for cervical cancer.
Naucler P; Ryd W; Törnberg S; Strand A; Wadell G; Elfgren K; Rådberg T; Strander B; Johansson B; Forslund O; Hansson BG; Rylander E; Dillner J
N Engl J Med; 2007 Oct; 357(16):1589-97. PubMed ID: 17942872
[TBL] [Abstract][Full Text] [Related]
25. High-risk HPV DNA detection by Hybrid Capture II. An adjunctive test for mildly abnormal cytologic smears in women > or = 50 years of age.
Lin CT; Tseng CJ; Lai CH; Hsueh S; Huang HJ; Law KS
J Reprod Med; 2000 Apr; 45(4):345-50. PubMed ID: 10804494
[TBL] [Abstract][Full Text] [Related]
26. Utility of the in situ detection of HPV in Pap smears diagnosed as within normal limits.
Menezes G; Euscher E; Schwartz B; Catania F; Chancellor J; Nuovo GJ
Acta Cytol; 2001; 45(6):919-26. PubMed ID: 11726118
[TBL] [Abstract][Full Text] [Related]
27. [Management of a low grade smear].
Baldauf JJ; Ritter J
Contracept Fertil Sex; 1999 Apr; 27(4):269-74. PubMed ID: 10349768
[No Abstract] [Full Text] [Related]
28. Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia.
Monsonego J; Pintos J; Semaille C; Beumont M; Dachez R; Zerat L; Bianchi A; Franco E
Int J Gynecol Cancer; 2006; 16(2):591-8. PubMed ID: 16681731
[TBL] [Abstract][Full Text] [Related]
29. Atypical squamous cells of undetermined significance in liquid-based cytologic specimens: results of reflex human papillomavirus testing and histologic follow-up in routine practice with comparison of interpretive and probabilistic reporting methods.
Levi AW; Kelly DP; Rosenthal DL; Ronnett BM
Cancer; 2003 Aug; 99(4):191-7. PubMed ID: 12925979
[TBL] [Abstract][Full Text] [Related]
30. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico.
Salmerón J; Lazcano-Ponce E; Lorincz A; Hernández M; Hernández P; Leyva A; Uribe M; Manzanares H; Antunez A; Carmona E; Ronnett BM; Sherman ME; Bishai D; Ferris D; Flores Y; Yunes E; Shah KV
Cancer Causes Control; 2003 Aug; 14(6):505-12. PubMed ID: 12948281
[TBL] [Abstract][Full Text] [Related]
31. The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13,842 women.
Bigras G; de Marval F
Br J Cancer; 2005 Sep; 93(5):575-81. PubMed ID: 16136031
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of the effectiveness of BMRT-HPV for cervical cancer screening].
Duan LF; Du H; Wang C; Huang X; Qu XF; Duan XZ; Liu Y; Shi B; Zhang W; Wei LH; Belinson L; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Oct; 55(10):708-715. PubMed ID: 33120484
[No Abstract] [Full Text] [Related]
33. Immediate histopathologic follow-up of cervista and aptima high-risk HPV assays in women with LSIL cytology.
Zhang H; Varma KR; Han M; Matsko J; Zhao C
Cancer Cytopathol; 2018 Aug; 126(8):525-532. PubMed ID: 29797678
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer.
Berkhof J; Meijer CJ
N Engl J Med; 2008 Feb; 358(6):642; author reply 643. PubMed ID: 18265441
[No Abstract] [Full Text] [Related]
35. Carbonic anhydrase IX and human papillomavirus as diagnostic biomarkers of cervical dysplasia/neoplasia in women with a cytologic diagnosis of atypical glandular cells: a Gynecologic Oncology Group study in United States.
Liao SY; Rodgers WH; Kauderer J; Bonfiglio TA; Walker JL; Darcy KM; Carter R; Hatae M; Levine L; Spirtos NM; Stanbridge EJ
Int J Cancer; 2009 Nov; 125(10):2434-40. PubMed ID: 19670419
[TBL] [Abstract][Full Text] [Related]
36. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Manos MM; Kinney WK; Hurley LB; Sherman ME; Shieh-Ngai J; Kurman RJ; Ransley JE; Fetterman BJ; Hartinger JS; McIntosh KM; Pawlick GF; Hiatt RA
JAMA; 1999 May; 281(17):1605-10. PubMed ID: 10235153
[TBL] [Abstract][Full Text] [Related]
37. The value of monitoring human papillomavirus DNA results for Papanicolaou tests diagnosed as atypical squamous cells of undetermined significance: a College of American Pathologists Q-Probes study of 68 institutions.
Tworek JA; Jones BA; Raab S; Clary KM; Walsh MK
Arch Pathol Lab Med; 2007 Oct; 131(10):1525-31. PubMed ID: 17922588
[TBL] [Abstract][Full Text] [Related]
38. Detection of human papillomavirus on Papanicolaou-stained cervical smears using indirect in situ polymerase chain reaction hybridization.
Manavi M; Bauer M; Pischinger K; Czerwenka K
Arch Pathol Lab Med; 2001 Mar; 125(3):353-7. PubMed ID: 11231482
[TBL] [Abstract][Full Text] [Related]
39. HPV primary screening for cervical cancer: more pain than protection.
Davey DD; Armenti CA
Diagn Cytopathol; 2000 Jun; 22(6):333-5. PubMed ID: 10820524
[No Abstract] [Full Text] [Related]
40. Screening based on papillomavirus detection: too many false alarms.
Prescrire Int; 2010 Aug; 19(108):178-9. PubMed ID: 20939456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
